US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 1.365
  • -0.045-3.19%
Close Apr 26 16:00 ET
  • 1.369
  • +0.004+0.32%
Post 19:28 ET
66.40MMarket Cap-1229P/E (TTM)

Cue Biopharma Key Stats

Cue Biopharma Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Apr 8, 2024

Revenue(YoY)

1.82M

+1105.96%
EPS(YoY)

-0.29

+23.68%

Strong Buy

Apr 9, 2024

Cue Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.272M--
--2024/Q1-- / 1.213M--
Apr 8, 20242023/Q41.821M / 1.567M--
Nov 9, 20232023/Q32.100M / 1.120M--
Aug 9, 20232023/Q21.382M / 907.500K--
--2023/Q1187.000K / 1.950M--
Mar 21, 20232022/Q4151.230K / 103.750K--
Nov 14, 20222022/Q368.000K / 440.330K--
Aug 23, 20222022/Q226.000K / 1.131M--
--2022/Q11.000M / 2.922M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.272M--
--2024/Q1-- / 1.213M--
Apr 8, 20242023/Q41.821M / 1.567M--
Nov 9, 20232023/Q32.100M / 1.120M--
Aug 9, 20232023/Q21.382M / 907.500K--
--2023/Q1187.000K / 1.950M--
Mar 21, 20232022/Q4151.230K / 103.750K--
Nov 14, 20222022/Q368.000K / 440.330K--
Aug 23, 20222022/Q226.000K / 1.131M--
--2022/Q11.000M / 2.922M--

Unlock Free Earnings Estimates

Cue Biopharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 9, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg